AIM & TSX: “TGL” & NASDAQ: “TGA” This Announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 (“MAR”). Upon the publication of this Announcement, this inside information is now considered to be in the public domain. CALGARY, Alberta, Jan. 24, 2019 (GLOBE NEWSWIRE) -- TransGlobe Energy Corporation (“TransGlobe” or the “Company”) today announces its 2018 year-end reserves. All dollar values are expressed in United States dollars unless otherwise stated. /EIN News/ -- EXECUTIVE SUMMARY Total proved (“1P”) gross reserves of 26.9 million barrels oil equivalent (“MMboe”) (YE 2017: 27.5 MMboe) representing a 0.6 MMboe or 2% decrease from year-end 2017 primarily due to production of ~5.3 MMboe during the year, substantially offset by ~4.7 MMboe of positive net revisions. Total proved plus probable (“2P”) gross reserves of … [Read more...] about TransGlobe Energy Corporation Announces Its 2018 Year-End Reserves
News by Industry
/EIN News/ -- COPENHAGEN, Denmark, January 24, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) reports further progress in the development of a prophylactic vaccine against the equine encephalitis virus - a rare, but potentially deadly illness. The program, which is funded by the United States Department of Defense (DoD) Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) through a multi-year agreement of up to USD 36 million, aims to develop a vaccine against three separate strains of the equine encephalitis virus, Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV), for which there are currently no preventative vaccines available. The vaccine is based on Bavarian Nordic's proprietary, poxviral MVA-BN® platform, which due to its large genome is able to encode multiple antigens, thus providing the potential to protect against multiple diseases. Since award of the contract in March 2018, Bavarian Nordic has received incremental funding to support … [Read more...] about Bavarian Nordic Advances Development of Equine Encephalitis Virus Vaccine
BENSALEM, Pa., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors of the February 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Immunomedics, Inc. (“Immunomedics” or the “Company”) (NASDAQ: IMMU) securities between August 23, 2018 and December 20, 2018, inclusive (the “Class Period”). Immunomedics investors have until February 25, 2019 to file a lead plaintiff motion. Investors suffering losses on their Immunomedics investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] On December 17, 2018, FDAnews published an article reporting that “[t]he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris … [Read more...] about Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Immunomedics, Inc.
NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you. /EIN News/ -- PPDAI Group Inc. (NYSE: PPDF)Purchasers of American Depositary Shares (1) pursuant or traceable to the F-1 registration statement, the F-6 registration statement, and related Prospectus issued in connection with PPDAI’s initial public stock offering held on or about November 10, 2017 (the “IPO” or “Offering”) and/or (2) between November 10, 2017 and December 1, 2017Lead Plaintiff Deadline: January 25, 2019https://www.zlk.com/pslra-1/ppdai-group-inc-ppdf-loss-form?wire=3 Allegations: PPDAI Group Inc. made materially false and/or … [Read more...] about CLASS ACTION UPDATE for PPDF, YRCW and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you. /EIN News/ -- Danske Bank A/S (OTCMKTS: DNKEY)Purchasers of American Depositary Receipts between January 9, 2014 and October 23, 2018Lead Plaintiff Deadline: March 11, 2019https://www.zlk.com/pslra-1/danske-bank-a-s-loss-form?wire=3 The lawsuit alleges: Danske Bank A/S made materially false and/or misleading statements and/or failed to disclose that: (i) Danske Bank’s Estonian branch was facilitating money laundering through at least March 2016; (ii) that a whistleblower had reported the Estonian money laundering to the Company in 2013; (iii) that Denmark’s Financial … [Read more...] about CLASS ACTION UPDATE for DNKEY, NVDA and SNAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders